GUIDETTI, ANNA
GUIDETTI, ANNA
Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti
Age- and irradiation-associated loss of bone marrow hematopoietic function in mice is reversed by recombinant human growth hormone (rhGH)
2004-01-01 C. Carlo-Stella, M. Di Nicola, R. Milani, P. Longoni, M. Milanesi, C. Bifulco, C. Stucchi, A. Guidetti, L. Cleris, F. Formelli, G. Garotta, A.M. Gianni
Allogeneic transplantation for relapsed and refractory Hodgkin lymphoma : long-term outcomes and graft-versus-host disease-free/relapse-free survival
2018-05-01 F. Spina, T. Radice, C. De Philippis, M. Soldarini, M.C. Di Chio, A. Dodero, A. Guidetti, S. Viviani, P. Corradini
Are We Ready to Treat Diffuse Large B-cell and High-Grade Lymphoma According to Major Genetic Subtypes?
2019-10-01 A. Chiappella, J. Crombie, A. Guidetti, U. Vitolo, P. Armand, P. Corradini
Boosting T cell-mediated immunity to tyrosinase by vaccinia virus-transduced, CD34+-derived dendritic cell vaccination: a phase I trial in metastatic melanoma
2004-08-15 M. Di Nicola, C. Carlo-Stella, R. Mortarini, P. Baldassari, A. Guidetti, F. Gallino, M. Del Vecchio, F. Ravagnani, M. Magni, P. Chaplin, N. Cascinelli, G. Parmiani, A. Gianni, A. Anichini
Chemotherapy after PD-1 inhibitors in relapsed/refractory Hodgkin lymphoma: Outcomes and clonal evolution dynamics
2022-04-25 E. Calabretta, A. Guidetti, F. Ricci, M. Di Trani, C. Monfrini, M. Magagnoli, S. Bramanti, D. Maspero, L. Morello, M. Merli, A. Di Rocco, A. Graudenzi, E. Derenzini, M. Antoniotti, D. Rossi, P. Corradini, A. Santoro, C. Carlo-Stella
Clinical protocol. Immunization of patients with malignant melanoma with autologous CD34+ cell-derived dendritic cells transduced ex vivo with a recombinant replication-deficient vaccinia vector encoding the human tyrosinase gene: a phase I trial
2003-01-01 M. Di Nicola, C. Carlo-Stella, A. Anichini, R. Mortarini, A. Guidetti, G. Tragni, F. Gallino, M. Del Vecchio, F. Ravagnani, D. Morelli, P. Chaplin, N. Arndtz, G. Sutter, I. Drexler, G. Parmiani, N. Cascinelli, A.M. Gianni
Cytokine secretion associated with the clearance of apoptotic bodies in renal cell carcinoma patients
2001-03-20 A. Bondanza, P. Rovere, A. Borri, E.R. Caremoli, A. Guidetti, G. Citterio, G. Consogno, V.S. Zimmermann, C. Rugarli, A.A. Manfredi
Detection of minimal residual disease in hematopoietic progenitor cell harvests : lack of predictive value of peripheral blood and bone marrow analysis in mantle cell and indolent lymphoma
2012-01-01 M. Magni, M.D. Nicola, C. Carlo-Stella, P. Matteucci, L. Devizzi, A. Guidetti, F. Ravagnani, A.M. Gianni
Early reduction of serum TARC levels may predict for success of ABVD as frontline treatment in patients with Hodgkin Lymphoma
2017-11-01 A. Guidetti, M. A., M. R., E.V.M. Paterno', T. F., S. F., C. F., F. L., P. Corradini, G. A. M., V. S.
Efficacy and safety of high-dose chemotherapy with in vivo purged auto-SCT in relapsed follicular lymphoma : long-term follow-up
2010-06-01 M. Magni, M. Di Nicola, C. Carlo Stella, L. Devizzi, A. Guidetti, P. Matteucci, A. Gianni
Genetic and Phenotypic Attributes of Splenic Marginal Zone Lymphoma
2021-01-01 F. Bonfiglio, A. Bruscaggin, F. Guidetti, L. Terzi di Bergamo, M.R. Faderl, V. Spina, A. Condoluci, L. Bonomini, G. Forestieri, R. Koch, D. Piffaretti, K. Pini, M.C. Pirosa, M.G. Cittone, A. Arribas, M. Lucioni, G. Ghilardi, W. Wu, L. Arcaini, M.J. Baptista, G. Bastidas, S. Beà, R. Boldorini, A. Broccoli, M.M. Bühler, V. Canzonieri, L. Cascione, L. Ceriani, S.B. Cogliatti, P. Corradini, E. Derenzini, L. Devizzi, S. Dietrich, A.R. Elia, F. Facchetti, G. Gaidano, J.F. Garcia, B. Gerber, P. Ghia, M. Gomes da Silva, G. Gritti, A. Guidetti, F. Hitz, G.G. Inghirami, M. Ladetto, A. López-Guillermo, E. Lucchini, A. Maiorana, R. Marasca, E. Matutes, V. Meignin, M. Merli, A.A. Moccia, M. Mollejo, C. Montalban, U. Novak, D.G. Oscier, F. Passamonti, F.A. Piazza, S. Pizzolitto, A. Rambaldi, E. Sabattini, G.A. Salles, E. Santambrogio, L. Scarfo, A. Stathis, G. Stussi, J.T. Geyer, G. Tapia, C. Tarella, C. Thieblemont, T. Tousseyn, A. Tucci, G. Vanini, C. Visco, U. Vitolo, R. Walewska, F. Zaja, T. Zenz, P.L. Zinzani, H. Khiabanian, A. Calcinotto, F. Bertoni, G. Bhagat, E. Campo, L. de Leval, S. Dirnhofer, S.A. Pileri, M.A. Piris, A. Traverse-Glehen, A. Tzankov, M. Paulli, M. Ponzoni, L. Mazzucchelli, F. Cavalli, E. Zucca, D. Rossi
High-dose chemotherapy followed by autologous transplantation may overcome the poor prognosis of diffuse large B-cell lymphoma patients with MYC/BCL2 co-expression
2016-11-01 F. Maura, A. Guidetti, A. Pellegrinelli, A. Dodero, M. Pennisi, C. Caprioli, A. Testi, L. Farina, N. Bolli, L.F. Devizzi, A.D. Cabras, P. Corradini
High-dose yttrium-90-ibritumomab tiuxetan with tandem stem-cell reinfusion : an outpatient preparative regimen for autologous hematopoietic cell transplantation
2008-01-01 L. Devizzi, A. Guidetti, C. Tarella, M. Magni, P. Matteucci, E. Seregni, C. Chiesa, E. Bombardieri, M. Di Nicola, C. Carlo Stella, A. Gianni
Inflammation and lymphoma: Therapeutic implications
2015-01-01 C.C. Stella, A. Guidetti, A. Santoro
Interferon gamma enhances the anti-myeloma activity of the fully human anti-HLA-DR monoclonal antibody ID09C3
2007-01-01 C. Carlo Stella, A. Guidetti, M. Di Nicola, C. Lavazza, L. Cleris, P. Longoni, M. Milanesi, M. Magni, Z. Nagy, P. Corradini, A. Carbone, F. Formelli, A.M. Gianni
Interferon γ enhances the anti-myeloma activity of the fully human anti-HLA-DR monoclonal antibody 1D09C3
2007-01-01 C. Carlo-Stella, A. Guidetti, M. Di Nicola, C. Lavazza, L. Cleris, D. Sia, P. Longoni, M. Milanesi, M. Magni, Z. Nagy, P. Corradini, A. Carbone, F. Formelli, A.M. Gianni
Long-term results of autologous hematopoietic stem-cell transplantation after high-dose 90Y-ibritumomab tiuxetan for patients with poor-risk non-Hodgkin lymphoma not eligible for high-dose BEAM
2013-08-10 L. Devizzi, A. Guidetti, E. Seregni, R. Passera, M. Maccauro, M. Magni, A. Testi, M. Di Nicola, C. Tarella, P. Matteucci, S. Viviani, M. Ruella, C. Carlo-Stella, C. Chiesa, M.C. Cox, E. Bombardieri, A.M. Gianni
Mobilization of primitive and committed hematopoietic progenitors in nonhuman primates treated with Defibrotide and recombinant human granulocyte colony-stimulating factor
2004-01-01 C. Carlo-Stella, M. Di Nicola, P. Longoni, R. Milani, M. Milanesi, A. Guidetti, K. Haanstra, M. Jonker, L. Cleris, M. Magni, F. Formelli, A.M. Gianni
Perifosine and sorafenib combination induces mitochondrial cell death and antitumor effects in NOD/SCID mice with Hodgkin lymphoma cell line xenografts
2013-08-01 S.L. Locatelli, A. Giacomini, A. Guidetti, L. Cleris, R. Mortarini, A. Anichini, A. Gianni, C. Carlo Stella
Phase II study of perifosine and sorafenib dual-targeted therapy in patients with relapsed or refractory lymphoproliferative diseases
2014-11-15 A. Guidetti, C. Carlo-Stella, S.L. Locatelli, W. Malorni, R. Mortarini, S. Viviani, D. Russo, A. Marchianò, R. Sorasio, A. Dodero, L. Farina, L. Giordano, M. Di Nicola, A. Anichini, P. Corradini, A.M. Gianni